Search

1 to 10 of 66
Sort by

Web Page
SITC Publishes Clinical Practice Guideline on Immunotherapy for Hepatocellular Carcinoma

FOR IMMEDIATE RELEASE September 23, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the...


Web Page
SITC Publishes Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events

FOR IMMEDIATE RELEASE July 14, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication...


Web Page
SITC Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer

FOR IMMEDIATE RELEASE Aug. 5, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated to cancer immunotherapy, has published a clinical practice guideline (CPG) to help clinicians use immunotherapy to improve their care of...


Web Page
SITC Publishes Clinical Immunotherapy Treatment Guidelines for Lymphoma

FOR IMMEDIATE RELEASE Jan. 7, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated solely to cancer immunotherapy, has published a clinical practice guideline for use of immunotherapy in patients with lymphoma, a type of...



Library Entry
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...


Web Page
SITC Publishes Clinical Practice Guideline on Immune Effector Cell-related Adverse Events

FOR IMMEDIATE RELEASE Dec. 18, 2020 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated solely to cancer immunotherapy, is pleased to announce the publication of a clinical practice guideline for the management of cell therapy...